CD47 and melanoma: In addition to increased CD8A and CD8B mRNA indicating that melanomas with elevated CD47 contain more CD8 T cells, the present data correlating CD47 with higher TIGIT, CD40LG, PD-1, TNF, and the antiapoptotic MCL1 suggests these intratumoral CD8 cells are more active and resistant to apoptotic death.